Verastem Oncology Reports First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. WDAY
2. NVDA
3. AAPL
4. JNJ
5. AMAT
6. META
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to Verastem Oncology Reports First Quarter 2019 Financial Results

Verastem (VSTM) Misses Q1 EPS by 5c, Revenues Miss; FY19 Revenue Guidance Below Consensus

May 9, 2019 4:47 PM EDT

Verastem (NASDAQ: VSTM) reported Q1 EPS of ($0.52), $0.05 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $1.67 million versus the consensus estimate of $2.91 million.

We are now into the second full quarter of the COPIKTRA launch and sales were up approximately 38% compared to the prior quarter, said Robert Forrester, President and Chief... More